Adial Pharmaceuticals, Inc. Debt Instrument, Face Amount
Adial Pharmaceuticals, Inc. (ADIL) had Debt Instrument, Face Amount of $325.00 thousand as of 2018-12-19, per its 10-K filed 2020-03-20.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2020-03-20
- 2018-12-19: Debt Instrument, Face Amount $325.00K.
- 2018-07-01: Debt Instrument, Face Amount $100.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2018-12-19 | $325.00K 10-K · filed 2020-03-20 |
| 2018-07-01 | $100.00K 10-K · filed 2020-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |